UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 102 filers reported holding ARATANA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$8,569,000
-14.2%
1,6290.0%0.00%
Q3 2017$9,986,000
-20.8%
1,629
-6.6%
0.00%
Q2 2017$12,616,000
+36.4%
1,7450.0%0.00%
Q1 2017$9,249,000
+61560.0%
1,745
-16.1%
0.00%
Q4 2016$15,000
-96.1%
2,079
-96.6%
0.00%
Q2 2016$387,000
-34.3%
61,267
-42.6%
0.00%
-100.0%
Q1 2016$589,000
-28.2%
106,685
-27.4%
0.00%0.0%
Q4 2015$820,000
+2.2%
146,936
+55.0%
0.00%0.0%
Q3 2015$802,000
+189.5%
94,808
+418.1%
0.00%
Q2 2015$277,000
+23.7%
18,300
+30.7%
0.00%
Q1 2015$224,000
-7.1%
14,000
+3.7%
0.00%
Q4 2014$241,000
+77.2%
13,5000.0%0.00%
Q3 2014$136,00013,5000.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
March Altus Capital Management LP 218,515$1,219,00011.21%
Broadfin Capital, LLC 3,428,865$19,133,0001.18%
MPM ASSET MANAGEMENT LLC 1,117,875$6,238,0001.11%
AlpInvest Partners B.V. 100,001$558,0000.93%
First Light Asset Management, LLC 395,043$2,204,0000.92%
Westend Capital Management, LLC 89,780$501,0000.69%
Grandeur Peak Global Advisors, LLC 460,675$2,571,0000.53%
AWM Investment Company, Inc. 467,507$2,609,0000.51%
HAMILTON LANE ADVISORS LLC 111,705$623,0000.27%
Sio Capital Management, LLC 97,376$543,0000.24%
View complete list of ARATANA THERAPEUTICS INC shareholders